Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NDRA NASDAQ:NXGL NASDAQ:OSRH NASDAQ:PETV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNDRAENDRA Life Sciences$4.39+2.6%$5.25$2.90▼$22.68$3.08M-0.1459,929 shs32,630 shsNXGLNexGel$2.30-2.1%$2.47$2.10▼$5.10$19.81M0.5847,706 shs47,618 shsOSRHOSR$0.60-17.1%$0.91$0.45▼$13.40$16.76M1.5113.87 million shs1.13 million shsPETVPetVivo$0.80+0.7%$0.81$0.40▼$0.98$22.32M0.7518,697 shs5,150 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNDRAENDRA Life Sciences+2.57%+6.81%-13.92%+29.88%-63.96%NXGLNexGel-2.13%-1.71%-11.54%-0.86%-18.15%OSRHOSR-17.08%-31.86%-8.32%-57.11%+60,049,900.00%PETVPetVivo+0.65%-5.75%+0.13%+3.90%-2.44%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNDRAENDRA Life Sciences1.7382 of 5 stars3.53.00.00.00.60.00.6NXGLNexGel0.4055 of 5 stars0.03.00.00.00.62.50.0OSRHOSRN/AN/AN/AN/AN/AN/AN/AN/APETVPetVivoN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNDRAENDRA Life Sciences 3.00Buy$50.001,038.95% UpsideNXGLNexGel 0.00N/AN/AN/AOSRHOSR 0.00N/AN/AN/APETVPetVivo 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNDRAENDRA Life SciencesN/AN/AN/AN/A$1.96 per shareN/ANXGLNexGel$8.69M2.14N/AN/A$0.63 per share3.65OSRHOSRN/AN/AN/AN/A$6.45 per shareN/APETVPetVivo$1.05M21.34N/AN/A($0.03) per share-26.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNDRAENDRA Life Sciences-$11.51M-$33.89N/AN/AN/AN/A-194.14%-127.89%11/21/2025 (Estimated)NXGLNexGel-$3.28M-$0.40N/A∞N/A-25.02%-49.37%-25.68%11/12/2025 (Estimated)OSRHOSR-$2.41MN/A0.00∞N/AN/A-12.19%-8.18%N/APETVPetVivo-$10.95M-$0.40N/A∞N/A-902.82%-4,813.07%-281.78%11/13/2025 (Estimated)Latest NDRA, OSRH, PETV, and NXGL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025NDRAENDRA Life Sciences-$2.27-$1.71+$0.56-$1.71N/AN/A8/14/2025Q2 2025OSRHOSRN/A$0.02N/A$0.02N/A$1.14 million8/12/2025Q2 2025NXGLNexGel-$0.07-$0.09-$0.02-$0.09$3.08 million$2.88 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNDRAENDRA Life SciencesN/AN/AN/AN/AN/ANXGLNexGelN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/APETVPetVivoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNDRAENDRA Life SciencesN/A3.213.21NXGLNexGel0.161.740.98OSRHOSRN/A0.180.17PETVPetVivo0.020.420.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNDRAENDRA Life Sciences1.19%NXGLNexGel2.21%OSRHOSR55.30%PETVPetVivo24.55%Insider OwnershipCompanyInsider OwnershipNDRAENDRA Life Sciences0.04%NXGLNexGel20.55%OSRHOSR33.67%PETVPetVivo10.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNDRAENDRA Life Sciences20750,000753,000Not OptionableNXGLNexGel108.07 million6.41 millionNot OptionableOSRHOSRN/A21.58 million14.32 millionN/APETVPetVivo2027.90 million19.06 millionNot OptionableNDRA, OSRH, PETV, and NXGL HeadlinesRecent News About These CompaniesPETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH NUPSALA LIMITEDSeptember 2 at 12:02 PM | markets.businessinsider.comFinancial Comparison: PetVivo (NASDAQ:PETV) and Titan Medical (NASDAQ:TMDIF)September 2 at 3:59 AM | americanbankingnews.comPetVivo Holdings, Inc.: PetVivo Reports Fiscal Q1 2026 ResultsAugust 16, 2025 | finanznachrichten.dePetVivo Holdings, Inc. (PETV) Q1 2026 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comPetVivo Reports Fiscal Q1 2026 ResultsAugust 14, 2025 | globenewswire.comPetVivo Sets Fiscal First Quarter 2026 Conference Call for Thursday, August 14, 2025 at 5:00 p.m. ETAugust 7, 2025 | globenewswire.comPetVivo Holdings Inc. to Trade on OTCQX Best MarketJuly 30, 2025 | globenewswire.comPetVivo Holdings, Inc. (OTC:PETV) Q4 2025 Earnings Call TranscriptJuly 3, 2025 | insidermonkey.comPetVivo Reports Fiscal 2025 Results - Seeking AlphaJuly 2, 2025 | seekingalpha.comPetVivo Reports Fiscal 2025 Results - MorningstarJuly 2, 2025 | morningstar.comMPetVivo Holdings, Inc.: PetVivo Reports Fiscal 2025 ResultsJuly 1, 2025 | finanznachrichten.dePetVivo Holdings Inc (PETV) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ExpansionJuly 1, 2025 | finance.yahoo.comPetVivo Holdings, Inc. (PETV) Q4 2025 Earnings Call TranscriptJune 30, 2025 | seekingalpha.comPetVivo Reports Fiscal 2025 ResultsJune 30, 2025 | globenewswire.comPetVivo Sets Fiscal Fourth Quarter 2025 Conference Call for Monday, June 30 at 5:00 p.m. ETJune 26, 2025 | globenewswire.comPetVivo Holdings completes $5 million preferred stock offeringJune 26, 2025 | investing.comPetVivo Holdings Completes $5M Equity Financing InitiativeJune 24, 2025 | tipranks.comPETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERINGJune 24, 2025 | globenewswire.comPETVIVO HOLDINGS, INC. ANNOUNCES INVESTOR EXERCISE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERINGJune 20, 2025 | globenewswire.comPetVivo Holdings Secures $3 Million from Equity OfferingJune 20, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNDRA, OSRH, PETV, and NXGL Company DescriptionsENDRA Life Sciences NASDAQ:NDRA$4.39 +0.11 (+2.57%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$4.37 -0.02 (-0.46%) As of 09/3/2025 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.NexGel NASDAQ:NXGL$2.30 -0.05 (-2.13%) Closing price 09/3/2025 03:59 PM EasternExtended Trading$2.29 -0.01 (-0.43%) As of 09/3/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.OSR NASDAQ:OSRH$0.60 -0.12 (-17.08%) As of 09/3/2025 03:59 PM EasternOSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.PetVivo NASDAQ:PETV$0.80 +0.01 (+0.65%) As of 09/3/2025 03:44 PM EasternPetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Zscaler Shares Can Hit a Fresh High Before Year-End Why Qualcomm Is Outperforming NVIDIA After Months of Lagging Alphabet Stock Surges After Dodging Harsh Antitrust Remedies Wall Street Punishes Dell's Record Quarter: Why They Are Wrong Taiwan Semiconductor Falls on China News—Buy The Dip? CrowdStrike Tests $412 Support as Options Traders Turn Bullish What to Expect From the Q3 Reporting Season IREN Is Up 186% YTD on AI Pivot—And It’s Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
